Rolls-Royce Holdings PLC (RR.L)
22 Mar 2019
March 3 British engine maker Rolls-Royce Holdings Plc confirmed it had scaled back efforts to join a Turkish programme to build a new fighter jet with Turkey's Kale Group.
BRUSSELS, March 4 The following are mergers under review by the European Commission and a brief guide to the EU merger process:
ISTANBUL Kale Group is waiting for Turkey's defence industry directorate to respond to its final offer for a new fighter jet programme, a company official said on Monday, after Britain's Rolls-Royce said it had scaled back efforts to join the programme.
ISTANBUL Kale Group is waiting for Turkey's defense industry directorate to respond to its final offer for a new fighter jet program, a company official said on Monday, after Britain's Rolls-Royce said it had scaled back efforts to join the program.
March 3 British engine maker Rolls-Royce has scaled back efforts to join a Turkish programme to build a new fighter jet, the Financial Times reported on Sunday.
LONDON Rolls-Royce dropped out of the race to power Boeing's planned mid-market aircraft on Thursday, saying it did not want to risk more disruption for its airline customers by rushing out a product without extensive testing. | Video
* Company increases costs of Trent engine fixes (Adds comments by sources on CFM engine, background)
Feb 28 Britain's FTSE 100 was lower on Thursday as Rolls-Royce slipped after dropping out the race for Boeing's mid-market aircraft, results dragged on British American Tobacco and miners fell on weak Chinese factory data.
LONDON, Feb 28 Rolls-Royce said it had withdrawn from a competition to power Boeing's planned mid-market aircraft because it could not meet the timetable, as the British group reported a full-year underlying operating profit of 616 million pounds ($819 million).
Feb 26 Britain's FTSE 100 index is seen opening 45 points lower at 7,139, on Tuesday, according to financial bookmakers, while FTSE 100 futures were down 0.64 percent ahead of the cash market open. * ASTRAZENECA: British drugmaker AstraZeneca Plc said on Tuesday its cancer drug being jointly developed with U.S.-based Merck & Co met the primary goal in a late-stage study for pancreatic cancer. * DRAX: British power producer Drax Group Plc reported a 9 percent rise in full-year core ea